InvestorsHub Logo
Followers 15
Posts 933
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Wednesday, 11/21/2018 7:14:02 AM

Wednesday, November 21, 2018 7:14:02 AM

Post# of 426495
People I think are getting far too caught up in the personality of Bhatt and Thero. With all due respect it’s the doctors and the FDA that need to be impressed with the data and presentation. Doctors can see bullshit from a mile away where many investors can not regarding the study and results. If the price had not dropped here no one would be questioning either person, but price has not dropped due to either one, it dropped due to some shaky press, coordinated selling and some panic setting in. All these items will come to an end. The worst thing Amarin could do is roll out people who feel like sleazy salespeople trying to push Vascepa at every turn. The drug works, the medical community hasn’t been fooled by the articles and Thero and Bhatt are still the right people to push forward. Thero doesn’t overpromise or overhype and the company is better off for it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News